Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.
FDA Approves First CRISPR Treatment in U.S.
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.